Atlas Trials

Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies

Clinical trial NCT02600351 · TERMINATED

Trial details

NCT number
NCT02600351
Sponsor
Gilead Sciences
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C Virus Infection
Start date
2015-11-11
Primary completion
2017-03-21
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.